LBA01 - LBA01: Late-Breaking Abstract I - Benign

Podium Presenter(s)

• AA

  Abdullatif Aydin
• AC

  Abhishek Chandna
• SC

  Sung Yong Cho
• 

  Marlie Elia, MD

  Cleveland Clinic Glickman Urological and Kidney Institute

  PDF Slides and Audio
• 

  Gregg Eure, MD

  Eastern Virginia Medical School

  PDF Slides and Audio
• 

  Bradley Gill, MD,MS

  MD, MS
  Cleveland Clinic

  PDF Slides and Audio
• 

  Bryn Launer

  University of Colorado School of Medicine

  PDF Slides and Audio
• 

  Kevin McVary, MD

  Professor and Chair
  Loyola University Medical Center

  PDF Slides and Audio
• JS

  Jessica Saw
• 

  Charles Scales, Jr., MD,FACS

  Duke University School of Medicine

  PDF Slides and Audio
• CS

  Claudia Signorini

  IRCCS Policlinico San Donato

  PDF Slides and Audio
• KT

  Krystal Thomas-White, PhD

Presentations:

• 7:00 AM – 9:00 AM

  LBA01-01: Fungi and Bacteria Entombed within Human Calcium Oxalate-Apatite Kidney Stones
  Jessica Saw
• 7:00 AM – 9:00 AM

  LBA01-02: 1990 to Now: Critical Global Trends in LUTS/BPH
  Bryn Launer
• 7:00 AM – 9:00 AM

  LBA01-03: Comparison of mirabegron, solifenacin and tamsulosin for stent related symptoms: a double blinded randomized control trial
  Abhishek Chandna
• 7:00 AM – 9:00 AM

  LBA01-04: Intraoperative Predictors of Sacral Neuromodulation Implantation & Treatment Response - Results from the ROSETTA Trial
  Bradley C. Gill, MD,MS – Cleveland Clinic
• 7:00 AM – 9:00 AM

  LBA01-05: Simulation in Urological Training and Education (SIMULATE): An International Randomised Controlled Clinical and Educational Trial to Determine the Effect of Simulation-based Surgical Training
  Abdullatif Aydin
• 7:00 AM – 9:00 AM

  LBA01-06: Five year results of the prospective, randomized controlled trial of water vapor thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia
  Kevin Thomas McVary, MD – Loyola Univesity Medical Center
• 7:00 AM – 9:00 AM

  LBA01-07: Prostatic Urethral Lift real-world experience is consistent with controlled trial results in both non-retention and retention subjects
  Gregg R. Eure, MD – Urology of Virginia
• 7:00 AM – 9:00 AM

  LBA01-08: Kidney stone risk and association with urine oxalate (UOx) levels in enteric hyperoxaluria (EH)
  Charles Douglas Scales, Jr., MD,FACS – Duke Health System-Urology Division
• 7:00 AM – 9:00 AM

  LBA01-09: Male lifestyle and pathological conditions associated with couple infertility in a referral center in Italy: a cross-sectional study of 13452 male patients.
  Claudia Signorini
• 7:00 AM – 9:00 AM

  LBA01-10: Mirabegron for Treatment of Overactive Bladder Symptoms in Patients with Parkinson's Disease: a Double-blind, Randomized Placebo-controlled Trial
  Sung Yong Cho
• 7:00 AM – 9:00 AM

  LBA01-11: Nephrolithiasis Disparity in People with Disabilities: Data from the National Health and Nutrition Examination Survey
  Marlie Elia, MD – Cleveland Clinic Glickman Urological and Kidney In
• 7:00 AM – 9:00 AM

  LBA01-12: Improvement in OAB Symptoms After Vaginal Estrogen Therapy Is Associated with Measurable Pelvic Microbiome Changes
  Krystal Thomas-White, PhD